Japanese firm’s AI algorithm for gastric cancer gets FDA’s Breakthrough Device designation

Categories
About this Disease New Findings

The Food and Drug Administration has provided a Breakthrough Device Designation for AI Medical Service’s’ machine learning algorithm that has the ability to analyze endoscopy images for potential diagnosis of gastric cancer.

https://medcitynews.com/2019/11/japanese-firms-ai-algorithm-for-gastric-cancer-gets-fdas-breakthrough-device-deisgnation/